Litigation Details for Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC (D. Del. 2018)

Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC (D. Del. 2018)

Docket		Date Filed	2018-12-19
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Colm Felix Connolly
Jury Demand	None	Referred To	Christopher J. Burke
Parties	AMPHASTAR PHARMACEUTICALS, INC.
Patents	10,086,010; 10,114,012; 10,252,010; 6,004,973; 6,024,981; 6,031,007; 6,197,341; 6,242,003; 6,264,981; 6,284,770; 6,316,023; 6,335,031; 6,414,016; 6,455,518; 6,592,903; 6,602,911; 6,716,867; 6,720,001; 6,780,889; 6,967,028; 7,101,576; 7,262,219; 7,297,703; 7,410,651; 7,431,943; 7,566,462; 7,566,714; 7,601,758; 7,612,073; 7,619,004; 7,659,282; 7,668,730; 7,727,987; 7,741,338; 7,765,106; 7,765,107; 7,767,656; 7,795,312; 7,820,681; 7,833,546; 7,851,482; 7,851,506; 7,888,342; 7,895,059; 7,906,519; 7,915,269; 7,919,115; 7,932,241; 7,935,731; 7,951,400; 7,964,219; 7,964,647; 7,964,648; 7,981,938; 7,994,220; 8,003,126; 8,008,003; 8,008,006; 8,013,002; 8,013,128; 8,017,074; 8,017,150; 8,026,393; 8,039,009; 8,039,030; 8,052,987; 8,058,052; 8,062,667; 8,067,416; 8,071,613; 8,093,296; 8,093,297; 8,093,298; 8,097,653; 8,097,655; 8,114,383; 8,168,209; 8,173,708; 8,192,722; 8,227,484; 8,242,131; 8,252,809; 8,263,125; 8,263,650; 8,283,379; 8,287,888; 8,287,903; 8,293,273; 8,298,576; 8,298,580; 8,309,060; 8,309,122; 8,318,745; 8,324,189; 8,324,275; 8,329,216; 8,329,752; 8,338,639; 8,362,085; 8,389,542; 8,404,215; 8,415,395; 8,415,396; 8,450,338; 8,457,988; 8,465,765; 8,475,832; 8,481,083; 8,497,256; 8,501,730; 8,563,033; 8,589,182; 8,591,938; 8,592,480; 8,598,233; 8,603,514; 8,642,012; 8,663,683; 8,731,963; 8,772,306; 8,778,390; 8,784,888; 8,808,737; 8,859,619; 8,871,779; 8,877,248; 8,895,064; 8,920,817; 9,000,002; 9,000,011; 9,000,021; 9,000,041; 9,005,016; 9,022,022; 9,024,007; 9,028,005; 9,035,085; 9,061,003; 9,375,478; 9,687,526; 9,744,209; 9,744,239; 9,750,785; 9,937,223; RE38,115; RE41,148; RE42,096; RE43,797; RE43,799
Attorneys	Daniel Roberts
Firms	Law Office of Michael R. Abram
Link to Docket	External link to docket

Biologic Drugs cited in Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC

Details for Par Pharmaceutical, Inc. v. Amneal Pharmaceuticals of New York, LLC (D. Del. 2018)

Date Filed	Document No.	Description	Snippet	Link To Document
2018-12-19	1		the ‘209 Patent”), 9,744,239 (“the ‘239 Patent”), 9,750,785 (“the ‘785 Patent”) and 9,937,223 (“the ‘223… United States Patent Nos. 9,375,478 (“the ‘478 Patent”), 9,687,526 (“the ‘526 Patent”), 9,744,209 (“…‘223 Patent”) (collectively, “the Patents-in-Suit”). This action is based upon the Patent Laws of the… The Patents-in-Suit 14. On June 28, 2016, the United States Patent and Trademark…copy of the ‘478 Patent is attached as Exhibit A. Par Pharmaceutical owns the ‘478 Patent. 15.	External link to document
2020-07-09	156	Exhibit 1	14. United States Patent No. 9,375,478 (“the ’478 patent”) is titled “Vasopressin Formulations…face of United States Patent No. 9,744,209 (“the ’209 patent”), the ’209 patent issued on August 29,…face of United States Patent No. 9,750,785 (“the ’785 patent”), the ’785 patent issued on September …in the ’239 patent. See, e.g., id. 162. The ’223 patent, like the ’239 patent, claims a vasopressin…Invalidity of the ’785 patent) Each of the claims of the ’785 patent are invalid for failure	External link to document
2020-07-09	157	Redacted Document	. 14. United States Patent No. 9,375,478 (“the ’478 patent”) is titled “Vasopressin Formulations…face of United States Patent No. 9,744,209 (“the ’209 patent”), the ’209 patent issued on August 29, …face of United States Patent No. 9,750,785 (“the ’785 patent”), the ’785 patent issued on September 5… in the ’239 patent. See, e.g., id. 162. The ’223 patent, like the ’239 patent, claims a vasopressin…(Invalidity of the ’785 patent) Each of the claims of the ’785 patent are invalid for failure	External link to document